Synthesis of small molecule CDC25 phosphatases inhibitors

被引：25
|
作者：
Contour-Galcéra, MO
Lavergne, O
Brezak, MC
Ducommun, B
Prévost, G
机构：
[1] Inst Henri Beaufour, Ipsen Res Labs, F-91966 Les Ulis, France
[2] Univ Toulouse 3, CNRS UMR 5088, LBCMCP, IFR109,Inst Explorat Fonct Genomes, F-31062 Toulouse, France
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2004年 / 14卷 / 23期
关键词：
CDC25; inhibitor; dual specificity phosphatases inhibitor; antiproliferative agent;
D O I：
10.1016/j.bmcl.2004.09.041
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
A targeted library of small molecules has been prepared to optimize the biological activity of BN82002, our initial lead compound, recently described as an original inhibitor of CDC25 phosphatases. Some of these compounds inhibit CDC25 in the micromolar range and therefore reinforce the interest of CDC25 as an anticancer target. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码：5809 / 5812
页数：4
相关论文
共 50 条
  • [41] Novel synthetic inhibitor of CDC25 phosphatases:: BN82002
    Brezak, MC
    Quaranta, M
    Mondésert, O
    Galcera, MO
    Lavergne, O
    Alby, F
    Cazales, M
    Baldin, W
    Thurieau, C
    Harnett, J
    Lanco, C
    Kasprzyk, PG
    Prevost, GP
    Ducommun, B
    CANCER RESEARCH, 2004, 64 (09) : 3320 - 3325
  • [42] CDC25 phosphatases in cancer cells: key players? Good targets?
    Boutros, Rose
    Lobjois, Valerie
    Ducommun, Bernard
    NATURE REVIEWS CANCER, 2007, 7 (07) : 495 - 507
  • [43] CDC25 phosphatases in cancer cells: key players? Good targets?
    Rose Boutros
    Valérie Lobjois
    Bernard Ducommun
    Nature Reviews Cancer, 2007, 7 : 495 - 507
  • [44] Independent mechanistic inhibition of Cdc25 phosphatases by a natural product caulibugulone
    Brisson, Marni
    Foster, Caleb
    Wipf, Peter
    Joo, Beomjun
    Tomko, Robert J., Jr.
    Nguyen, Theresa
    Lazo, John S.
    MOLECULAR PHARMACOLOGY, 2007, 71 (01) : 184 - 192
  • [45] Synthesis and Biological Evaluation of Metallocene-Tethered Peptidyl Inhibitors of CDC25
    Roy, Saonli
    Rangasamy, Loganathan
    Nouar, Assia
    Koenig, Christiane
    Pierroz, Vanessa
    Kaeppeli, Simon
    Ferrari, Stefano
    Patra, Malay
    Gasser, Gilles
    ORGANOMETALLICS, 2021, 40 (15) : 2716 - 2723
  • [46] Cdc25 phosphatases: Differential regulation by ubiquitin-mediated proteolysis
    Young, Lauren M.
    Pagano, Michele
    CELL CYCLE, 2010, 9 (23) : 4613 - 4614
  • [47] CDC25 Inhibitors as Anticancer Agents Are Moving Forward
    Brezak, M-C.
    Kasprzyk, P. G.
    Galcera, M-O.
    Lavergne, O.
    Prevost, G. P.
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2008, 8 (08) : 857 - 862
  • [48] What's new on CDC25 phosphatase inhibitors
    Contour-Galcera, Marie-Odile
    Sidhu, Alban
    Prevost, Gregoire
    Bigg, Dennis
    Ducommun, Bernard
    PHARMACOLOGY & THERAPEUTICS, 2007, 115 (01) : 1 - 12
  • [49] Medicinal chemistry insights into novel CDC25 inhibitors
    Tao, Yucen
    Hao, Xia
    Ding, Xiao
    Cherukupalli, Srinivasulu
    Song, Yuning
    Liu, Xinyong
    Zhan, Peng
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 201
  • [50] A Comprehensive Overview of the Developments of Cdc25 Phosphatase Inhibitors
    Abdelwahab, Ahmed Bakr
    El-Sawy, Eslam Reda
    Hanna, Atef G.
    Bagrel, Denyse
    Kirsch, Gilbert
    MOLECULES, 2022, 27 (08):
12345